Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses.

Li ZN, Weber KM, Limmer RA, Horne BJ, Stevens J, Schwerzmann J, Wrammert J, McCausland M, Phipps AJ, Hancock K, Jernigan DB, Levine M, Katz JM, Miller JD.

J Virol Methods. 2017 Jan 17;243:61-67. doi: 10.1016/j.jviromet.2017.01.008. [Epub ahead of print]

PMID:
28108183
2.

CDC Grand Rounds: Modeling and Public Health Decision-Making.

Fischer LS, Santibanez S, Hatchett RJ, Jernigan DB, Meyers LA, Thorpe PG, Meltzer MI.

MMWR Morb Mortal Wkly Rep. 2016 Dec 9;65(48):1374-1377. doi: 10.15585/mmwr.mm6548a4.

3.

Prevention and Control of Seasonal Influenza with Vaccines.

Grohskopf LA, Sokolow LZ, Broder KR, Olsen SJ, Karron RA, Jernigan DB, Bresee JS.

MMWR Recomm Rep. 2016 Aug 26;65(5):1-54. doi: 10.15585/mmwr.rr6505a1.

PMID:
27560619
4.

Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic.

Bell BP, Damon IK, Jernigan DB, Kenyon TA, Nichol ST, O'Connor JP, Tappero JW.

MMWR Suppl. 2016 Jul 8;65(3):4-11. doi: 10.15585/mmwr.su6503a2. Review.

PMID:
27389903
5.

H7N9: preparing for the unexpected in influenza.

Jernigan DB, Cox NJ.

Annu Rev Med. 2015;66:361-71. doi: 10.1146/annurev-med-010714-112311. Review.

PMID:
25386931
6.

Updated preparedness and response framework for influenza pandemics.

Holloway R, Rasmussen SA, Zaza S, Cox NJ, Jernigan DB.

MMWR Recomm Rep. 2014 Sep 26;63(RR-06):1-18.

7.

Response to Al-Husayni and Hassoun.

Uyeki TM, Jernigan DB.

J Clin Virol. 2014 Sep;61(1):176-7. doi: 10.1016/j.jcv.2014.05.016. No abstract available.

PMID:
24954471
8.

Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic.

Williams LO, Kupka NJ, Schmaltz SP, Barrett S, Uyeki TM, Jernigan DB.

J Clin Virol. 2014 May;60(1):27-33. doi: 10.1016/j.jcv.2014.01.016.

PMID:
24630481
9.

Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012.

Epperson S, Jhung M, Richards S, Quinlisk P, Ball L, Moll M, Boulton R, Haddy L, Biggerstaff M, Brammer L, Trock S, Burns E, Gomez T, Wong KK, Katz J, Lindstrom S, Klimov A, Bresee JS, Jernigan DB, Cox N, Finelli L; Influenza A (H3N2)v Virus Investigation Team..

Clin Infect Dis. 2013 Jul;57 Suppl 1:S4-S11. doi: 10.1093/cid/cit272.

PMID:
23794729
10.

Estimates of the number of human infections with influenza A(H3N2) variant virus, United States, August 2011-April 2012.

Biggerstaff M, Reed C, Epperson S, Jhung MA, Gambhir M, Bresee JS, Jernigan DB, Swerdlow DL, Finelli L.

Clin Infect Dis. 2013 Jul;57 Suppl 1:S12-5. doi: 10.1093/cid/cit273.

11.

Progress in global surveillance and response capacity 10 years after severe acute respiratory syndrome.

Braden CR, Dowell SF, Jernigan DB, Hughes JM.

Emerg Infect Dis. 2013 Jun;19(6):864-9. doi: 10.3201/eid1906.130192. Review.

12.

Novel framework for assessing epidemiologic effects of influenza epidemics and pandemics.

Reed C, Biggerstaff M, Finelli L, Koonin LM, Beauvais D, Uzicanin A, Plummer A, Bresee J, Redd SC, Jernigan DB.

Emerg Infect Dis. 2013 Jan;19(1):85-91. doi: 10.3201/eid1901.120124.

13.

Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response.

Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, Shively R, Brammer L, Burke SA, Villanueva JM, Balish A, Uyeki T, Mustaquim D, Bishop A, Handsfield JH, Astles R, Xu X, Klimov AI, Cox NJ, Shaw MW.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S36-43. doi: 10.1093/cid/ciq020.

PMID:
21342897
14.

Prevention of community-associated methicillin-resistant Staphylococcus aureus infection among Asian/Pacific Islanders: a qualitative assessment.

Ciccarone RM, Kim M, Tice AD, Nakata M, Effler P, Jernigan DB, Cardo DM, Sinkowitz-Cochran RL.

Hawaii Med J. 2010 Jun;69(6):142-4.

15.

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.

Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, López-Gatell H, Olivera H, López I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr, Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ.

Science. 2009 Jul 10;325(5937):197-201. doi: 10.1126/science.1176225.

16.

National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.

Cohen AL, Budnitz DS, Weidenbach KN, Jernigan DB, Schroeder TJ, Shehab N, Pollock DA.

J Pediatr. 2008 Mar;152(3):416-21. doi: 10.1016/j.jpeds.2007.07.041. Erratum in: J Pediatr. 2008 Jun;152(6):893.

PMID:
18280852
17.

Chronic disease and disasters medication demands of Hurricane Katrina evacuees.

Jhung MA, Shehab N, Rohr-Allegrini C, Pollock DA, Sanchez R, Guerra F, Jernigan DB.

Am J Prev Med. 2007 Sep;33(3):207-10.

PMID:
17826580
18.

A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy.

Sunenshine RH, Tan ET, Terashita DM, Jensen BJ, Kacica MA, Sickbert-Bennett EE, Noble-Wang JA, Palmieri MJ, Bopp DJ, Jernigan DB, Kazakova S, Bresnitz EA, Tan CG, McDonald LC.

Clin Infect Dis. 2007 Sep 1;45(5):527-33.

PMID:
17682984
19.

Methicillin-resistant Staphylococcus aureus infections among healthy full-term newborns.

James L, Gorwitz RJ, Jones RC, Watson JT, Hageman JC, Jernigan DB, Lord Y, Caballes N, Cortes C, Golash RG, Price JS, Gerber SI.

Arch Dis Child Fetal Neonatal Ed. 2008 Jan;93(1):F40-4.

PMID:
17412749
20.

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.

Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, Hebden J, Cosgrove SE, Anderson A, Carnell J, Jernigan DB, Kleinbaum DG, Perl TM, Standiford HC, Srinivasan A.

Emerg Infect Dis. 2007 Jan;13(1):97-103.

Items per page

Supplemental Content

Loading ...
Support Center